Treatment of secondary erythromatosis following renal transplantation by ACE-in hibitors
- VernacularTitle:血管紧张素转换酶抑制剂治疗肾移植后继发性红细胞增多症
- Author:
Zhihao YANG
;
Zhao ZHANG
;
Yongjin JIANG
- Publication Type:Journal Article
- From:
Chinese Journal of Organ Transplantation
2001;22(1):22-23
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the therapeutic effects and safety of angiotensin-converting enzym e (ACE)-inhibitors in the treatment of the secondary erythromatosis following ren al transplantation.Methods Twenty-four patients with erythromatosis following renal transplantation recei ved the treatment with ACE-inhibitors. During the administration of ACE-inhibi tors, the hemoglobin, hematocrit and the side effects were observed. Results All the patients were recovered except one who ha d to be stopped the treatment of ACE-inhibitors because of the depressing of th e blood pressure. The time of producing the effects was 7-20 days. The side effe cts included lower blood pressure accompanied by dizzy in 3 cases, anemia in 2 cases and damage to renal function in 2 cases. Conclusions ACE-inhibitors were effective in the treatme nt of secondary erythromatosis following renal transplantation. It was important to monitor the hemogram and the renal function of the patients.
